Works Cited

1. Schuckit MA. The treament of stimulant dependence.Addiction. 1994;89(11):1559-1563.

2. National Institute on Drug Abuse. Cocaine: DrugFacts. Available at https://nida.nih.gov/publications/drugfacts/cocaine. Last accessed March 30, 2023.

3. Orson FM, Kinsey BM, Singh RA, Wu Y, Kosten TR. Vaccines for cocaine abuse. Hum Vaccin. 2009;5(4):194-199.

4. National Institute on Drug Abuse. Methamphetamine: DrugFacts. Available at https://nida.nih.gov/publications/drugfacts/methamphetamine. Last accessed March 30, 2023.

5. National Institute on Drug Abuse. Cocaine Research Report: What is Cocaine? Available at https://nida.nih.gov/publications/research-reports/cocaine/what-cocaine. Last accessed March 30, 2023.

6. Kreek MJ, Levran O, Reed B, Schlussman SD, Zhou Y, Butelman ER. Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J Clin Invest. 2012;122(10):3387-3393.

7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Text Revision. Arlington, VA: American Psychiatric Publishing; 2022.

8. Gold MS, Paczynski RP. Cocaine and crack: clinical aspects. In: Lowinson JH, Ruiz P, Strain EC (eds). Substance Abuse: A Comprehensive Textbook. 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2011: 191-213.

9. Cornish JW, O'Brien CP. Crack cocaine abuse: an epidemic with many public health consequences. Annu Rev Public Health. 1996;17:259-273.

10. Ries RK, Fiellin DA, Miller SC, Saitz R. Principles of Addiction Medicine. 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2014.

11. Negrete JC. Cocaine problems in the coca-growing countries of South America. Ciba Found Symp. 1992;166:40-50.

12. Brownlow HA, Pappachan J. Pathophysiology of cocaine abuse. Eur J Anaesthesiol. 2002;19(6):395-414.

13. Prakash A, Das G. Cocaine and the nervous system. Int J Clin Pharmacol Ther Toxicol. 1993;31(12):575-581.

14. Gootenberg P (ed). Cocaine: Global Histories. New York, NY: Routledge; 1999.

15. Das G. Cocaine abuse in North America: a milestone in history. J Clin Pharmacol. 1993;33(4):296-310.

16. Musto DF. Cocaine's history, especially the American experience. Ciba Found Symp. 1992;166:7-14.

17. Withers NW, Pulvirenti L, Koob GF, Gillin JC. Cocaine abuse and dependence. J Clin Psychopharmacol. 1995;15(1):63-78.

18. Center for Behavioral Health Statistics and Quality. Key Substance Use and Mental Health Indicators in the United States: Results from the 2021 National Survey on Drug Use and Health. Available at https://www.samhsa.gov/data/sites/default/files/reports/rpt39443/2021NSDUHFFRRev010323.pdf. Last accessed March 30, 2023.

19. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings and Detailed Tables. Available at https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2015/NSDUH-FFR1-2015/NSDUH-FFR1-2015.htm. Last accessed March 30, 2023.

20. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS) 2020: Admissions to and Discharges from Publicly-Funded Substance Use Treatment. Available at https://www.samhsa.gov/data/sites/default/files/reports/rpt38665/2020_TEDS Annual Report-508 compliant_1182023_FINAL.pdf. Last accessed March 30, 2023.

21. Maurer HH, Sauer C, Theobald DS. Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine. Ther Drug Monit. 2006;28(3):447-453.

22. Zakharova E, Wade D, Izenwasser S. Sensitivity to cocaine conditioned reward depends on sex and age. Pharmacol Biochem Behav. 2009;92(1):131-134.

23. National Institute on Drug Abuse. How is Cocaine Abuse Treated. Available at https://nida.nih.gov/publications/research-reports/cocaine/what-treatments-are-effective-cocaine-abusers. Last accessed March 30, 2023.

24. Sofuoglu M, Kosten TR. Novel approaches to the treatment of cocaine addiction. CNS Drugs. 2005;19(1):13-25.

25. Farnsworth SJ, Volz TJ, Hanson GR, Fleckenstein AE. Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation. J Pharmacol Exp Ther. 2009;328(3):807-812.

26. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 1987;237(4819):1219-1223.

27. Thomsen M, Hall FS, Uhl GR, Caine SB. Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice. J Neuroscience. 2009;29(4):1087-1092.

28. Fowler JS, Volkow ND, Wang GJ, Gatley SJ, Logan J. Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy. Nucl Med Biol. 2001;28(5):561-572.

29. Burnett LB, Roldan CJ, Adler J. Cocaine Toxicity. Available at http://emedicine.medscape.com/article/813959-overview. Last accessed March 30, 2023.

30. Knuepfer MM. Cardiovascular disorders associated with cocaine use: myths and truths. Pharmacol Ther. 2003;97(3):181-222.

31. Schwartz BG, Rezkalla S, Kloner RA. Cardiovascular effects of cocaine. Circulation. 2010;122(24):2558-2569.

32. Zickler P. Methamphetamine, Cocaine Abusers Have Different Patterns of Drug Use, Suffer Different Cognitive Impairments. Available at https://www.ehd.org/health_meth_13.php. Last accessed March 30, 2023.

33. Zuffa G. Cocaine: Towards a Self-Regulation Model. Available at https://www.tni.org/en/briefing/cocaine-towards-self-regulation-model. Last accessed March 30, 2023.

34. National Institutes of Health. Tiny RNA Molecule in the Brain Curbs Cocaine Use. Available at https://www.nih.gov/news-events/nih-research-matters/tiny-rna-molecule-brain-curbs-cocaine-use. Last accessed March 30, 2023.

35. London ED, Bonson KR, Ernst M, Grant S. Brain imaging studies of cocaine abuse: implications for medication development.Crit Rev Neurobiol. 1999;13(3):227-242.

36. Nnadi CU, Mimiko OA, McCurtis HL, Cadet JL. Neuropsychiatric effects of cocaine use disorders. J Natl Med Assoc. 2005;97(11): 1504-1515.

37. Woicik PA, Moeller SJ, Alia-Klein N, et al. The neuropsychology of cocaine addiction: recent cocaine use masks impairment. Neuropsychopharmacology. 2009;34(5):1112-1122.

38. Orsini CA, Colon-Perez LM, Heshmati SC, Setlow B, Febo M. Functional connectivity of chronic cocaine use reveals progressive neuroadaptations in neocortical, striatal, and limbic networks. eNeuro. 2018;5(4):0081-0118.

39. van den Brink W, van Ree JM. Pharmacological treatments for heroin and cocaine addiction. Eur Neuropsychopharmacol. 2003;13(6):476-487.

40. Baum MK, Rafie C, Lai S, Sales S, Page B, Campa A. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J Acquir Immune Defic Syndr. 2009;50(1):93-99.

41. Goldenberg SM, Gallardo Cruz M, Strathdee SA, Nguyen L, Semple SJ, Patterson TL. Correlates of unprotected sex with female sex workers among male clients in Tijuana, Mexico. Sex Transm Dis. 2010;37(5):319-324.

42. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2003–2013 National Admissions to Substance Abuse Treatment Services. Available at https://www.samhsa.gov/data/sites/default/files/2013_Treatment_Episode_Data_Set_National/2003_2013_Treatment_Episode_Data_Set_National_Body.html. Last accessed March 30, 2023.

43. Science Daily. Cocaine Exposure During Pregnancy Leads To Impulsivity In Male, Not Female, Monkeys. Available at https://www.sciencedaily.com/releases/2009/10/091022114309.htm. Last accessed March 30, 2023.

44. Buckingham-Howes S, Berger SS, Scaletti LA, Black MM. Systematic review of prenatal cocaine exposure and adolescent development. Pediatrics. 2013;131(6):e1917-e1936.

45. Ganapathy V. Drugs of abuse and human placenta. Life Sci. 2011;88(21-22):926-930.

46. Richardson GA, De Genna NM, Goldschmidt L, Larkby C, Donovan JE. Prenatal cocaine exposure: direct and indirect associations with 21-year-old offspring substance use and behavior problems. Drug Alcohol Depend. 2019;195:121-131.

47. Richardson GA, Goldschmidt L, Larkby C, Day NL. Effects of prenatal cocaine exposure on adolescent development. Neurotoxicol Teratol. 2015;49:41-48.

48. Mendoza R, Miller BL. Neuropsychiatric disorders associated with cocaine use. Hosp Community Psychiatry. 1992;43(7):677-678, 680.

49. Pavarin R, Lugoboni F, Mathewson S, Ferrari AM, Guizzardi G, Quaglio G. Cocaine-related medical and trauma problems: a consecutive series of 743 patients from a multicentre study in Italy. Eur J Emerg Med. 2011;18(4):208-214.

50. Mathias R. [Archive]. Rate and Duration of Drug Activity Play Major Roles in Drug Abuse, Addiction, and Treatment. Available at https://archives.drugabuse.gov/news-events/nida-notes/1997/04/rate-duration-drug-activity-play-major-roles-in-drug-abuse-addiction-treatment. Last accessed March 30, 2023.

51. Ahmadi J, Kampman KM, Oslin DM, Pettinati HM, Dackis C, Sparkman T. Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment. Am J Addict. 2009;18(1):81-86.

52. Gossop M, Manning V, Ridge G. Concurrent use of alcohol and cocaine: differences in patterns of use and problems among users of crack cocaine and cocaine powder. Alcohol Alcohol. 2006;41(2):121-125.

53. Stitzer ML, Walsh SL. Psychostimulant abuse: the case for combined behavioral and pharmacological treatments. Pharmacol Biochem Behav. 1997;57(3):457-470.

54. National Institute on Drug Abuse. A "New Vista" for Treating Cocaine Addiction. Available at https://nida.nih.gov/news-events/science-highlight/new-vista-treating-cocaine-addiction. Last accessed March 30, 2023.

55. Penberthy JK, Ait-Daoud N, Vaughan M, Fanning T. Review of treatment for cocaine dependence. Curr Drug Abuse Rev. 2010;3(1):49-62.

56. National Institute for Health and Care Excellence. Drug Misuse in Over 16s: Psychosocial Interventions. Available at https://www.nice.org.uk/guidance/cg51. Last accessed March 30, 2023.

57. Woody GE. Research findings on psychotherapy of addictive disorders. Am J Addict. 2003;12(Suppl 2):S19-S26.

58. Stoops WW, Lile JA, Rush CR. Monetary alternative reinforcers more effectively decrease intranasal cocaine choice than food alternative reinforcers. Pharmacol Biochem Behav. 2010;95(2):187-191.

59. Barry D, Sullivan B, Petry NM. Comparable efficacy of contingency management for cocaine dependence among African American, Hispanic, and White methadone maintenance clients. Psychol Addict Behav. 2009;23(1):168-174.

60. Peirce JM, Petry NM, Stitzer ML, et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry. 2006;63(2):201-208.

61. Higgins ST, Heil SH, Dantona R, Donham R, Matthews M, Badger GJ. Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients. Addiction. 2007;102(2):271-281.

62. Stitzer ML, Petry NM, Peirce J. Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network.J Subst Abuse Treat. 2010;38(Suppl 1):S61-S69.

63. Herin DV, Rush CR, Grabowski J. Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Ann NY Acad Sci. 2010;1187:76-100.

64. García-Fernández G, Secades-Villa R, García-Rodríguez O, et al. Long-term benefits of adding incentives to the community reinforcement approach for cocaine dependence. Eur Addict Res. 2011;17(3):139-145.

65. Meyers RJ, Roozen HG, Smith JE. The community reinforcement approach: an update of the evidence. Alcohol Res Health. 2011;33(4):380-388.

66. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change: applications to addictive behaviors. Am Psychol. 1992;47(9):1102-1114.

67. Crits-Christoph P, Gallop R, Temes CM, et al. The alliance in motivational enhancement therapy and counseling as usual for substance use problems. J Consult Clin Psychol. 2009;77(6):1125-1135.

68. Rohsenow DJ, Monti PM, Martin RA, et al. Motivational enhancement and coping skills training for cocaine abusers: effects on substance use outcomes. Addiction. 2004;99(7):862-874.

69. Monti PM, O'Leary TA. Coping and social skills training for alcohol and cocaine dependence. Psychiatr Clin North Am. 1999;22(2): 447-470.

70. Michalec E, Zwick WR, Monti PM, et al. A Cocaine High-Risk Situations Questionnaire: development and psychometric properties.J Subst Abuse. 1992;4(4):377-391.

71. Crits-Christoph P, Siqueland L, Blaine J, et al. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry. 1999;56(6):493-502.

72. Weiss RD, Griffin ML, Gallop RJ, et al. The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patients. Drug Alcohol Dependence. 2005;77(2):177-184.

73. Grabowski J, Shearer J, Merrill J, Negus SS. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav. 2004;29(7):1439-1464.

74. Pani PP, Trogu E, Vecchi S, Amato L. Antidepressants for cocaine dependence and problematic cocaine use. Cochrane Database Syst Rev. 2011;(12):CD002950.

75. Castells X, Cunill R, Pérez-Mañá C, Vidal X, Capellà D. Psychostimulant drugs for cocaine dependence. Cochrane Database Syst Rev. 2016;9:CD007380.

76. Anderson AL, Reid MS, Li SH, et al. Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend. 2009;104(1-2):133-139.

77. Schmitt KC, Reith ME. The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors. PLoS One. 2011;6(10):e25790.

78. Morgan PT, Pace-Schott E, Pittman B, Stickgold R, Malison RT. Normalizing effects of modafinil on sleep in chronic cocaine users.Am J Psychiatry. 2010;167(3):331-340.

79. Sofuoglu M, Kosten TR. Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin Emerg Drugs. 2006;11(1):91-98.

80. Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology. 2005;30(1):205-211.

81. Morgan PT, Pace-Schott E, Pittman B, Stickgold R, Malison RT. Normalizing effects of modafinil on sleep in chronic cocaine users.Am J Psychiatry. 2010;167(3):331-340.

82. Martinez-Raga J, Knecht C, Cepeda S. Modafinil: a useful medication for cocaine addiction? Review of the evidence from neuropharmacological, experimental and clinical studies. Curr Drug Abuse Rev. 2008;1(2):213-221.

83. Quintero GC. Role of nucleus accumbens glutamatergic plasticity in drug addiction. Neuropsychiatr Dis Treat. 2013;9:1499-1512.

84. Sangroula D, Motiwala F, Wagle B, Shah VC, Hagi K, Lippmann S. Modafinil treatment of cocaine dependence: a systematic review and meta-analysis. Subst Use Misuse. 2017;52(10:1292-1306.

85. Minozzi S, Amato L, Pani PP, et al. Dopamine agonists for cocaine dependence. Cochrane Database Syst Rev. 2015;(5):CD003352.

86. Goldstein RZ, Woicik PA, Maloney T, et al. Oral methylphenidate normalizes cingulate activity in cocaine addiction during a salient cognitive task. Proc Natl Acad Sci U S A. 2010;107(38):16667-16672.

87. Minozzi S, Amato L, Pani PP, et al. Dopamine agonists for the treatment of cocaine dependence. Cochrane Database Syst Rev. 2015;(5):CD003352.

88. Indave BI, Minozzi S, Pani PP, Amato L. Antipsychotic medications for cocaine dependence. Cochrane Database Syst Rev. 2016;3:CD006306.

89. Pierce RC, O'Brien CP, Kenny PJ, Vanderschuren LJ. Rational development of addiction pharmacotherapies: successes, failures, and prospects. Cold Spring Harb Perspect Med. 2012;2(6):a012880.

90. Pani PP, Trogu E, Vacca R, Amato L, Vecchi S. Davoli M. Disulfiram for the treatment of cocaine dependence. Cochrane Database Syst Rev. 2010;1:CD007024.

91. Carroll KM, Nich C, Petry NM, Eagan DA, Shi JM, Ball SA. A randomized factorial trial of disulfiram and contingency management to enhance cognitive behavioral therapy for cocaine dependence. Drug Alcohol Depend. 2016;160:135-142.

92. Johnson BA. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function. CNS Drugs. 2005;19(10):873-896.

93. Prince B, Bowling KC. Topiramate in the treatment of cocaine use disorder. Am J Health Syst Pharm. 2018;75(1):e13-e22.

94. Shorter D, Kosten TR. Novel pharmacotherapeutic treatments for cocaine addiction. BMC Medicine. 2011;9:119.

95. Alvarez Y, Farré M, Fonseca F, Torrens M. Anticonvulsant drugs in cocaine dependence: a systematic review and meta-analysis.J Subst Abuse Treat. 2010;38(1):66-73.

96. Minozi S, Cinquini M, Amato L, et al. Anticonvulsants for cocaine dependence. Cochrane Database Syst Rev. 2015:4:CD006754.

97. Damodaran S. Cocaine and beta-blockers: the paradigm. Eur J Intern Med. 2010;21(2):84-86.

98. Young R, Glennon RA. S(-)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats. Psychopharmacology (Berl). 2009;203(2):369-382.

99. Kampman KM, Dackis C, Lynch KG, et al. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug Alcohol Depend. 2006;85(2):129-137.

100. Saladin ME, Gray KM, McRae-Clark AL, et al. A double blind, placebo-controlled study of the effects of post-retrieval propranolol on reconsolidation of memory for craving and cue reactivity in cocaine dependent humans. Psychopharmacology (Berl). 2013;226(4):721-737.

101. McCord J, Jneid H, Hollander JE, et al. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation. 2008;117:1897-1907.

102. Kantak KM. Vaccines against drugs of abuse: a viable treatment option? Drugs. 2003;63(4):341-352.

103. Carfora A, Cassandro P, Feola A, La Sala F, Petrella R, Borriello R. Ethical implications in vaccine pharmacotherapy for treatment and prevention of drug of abuse dependence. J Bioeth Inq. 2018;15(1):45-55.

104. Weiss F, Martin-Fardon R, Ciccocioppo R, Kerr TM, Smith DL, Ben-Shahar O. Enduring resistance to extinction of cocaine-seeking behavior induced by drug-related cues. Neuropsychopharmacology. 2001;25(3):361-372.

105. Weiss F, Ciccocioppo R, Parsons LH, et al. Compulsive drug-seeking behavior and relapse: neuroadaptation, stress, and conditioning factors. Ann N Y Acad Sci. 2001;937:1-26.

106. U.S. Food and Drug Administration. Pergolide (Marketed as Permax) Information. Available at https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/pergolide-marketed-permax-information. Last accessed March 30, 2023.

107. Higgins ST, Alessi SM, Dantona RL. Voucher-based incentives: a substance abuse treatment innovation. Addict Behav. 2002;27(6):887-910.

108. Silverman K, Higgins ST, Brooner RK, et al. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry. 1996;53(5):409-415.

109. Schubiner H, Saules KK, Arfken CL, et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol. 2002;10(3):286-294.

110. U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA Warns of Rare Risk of Long-Lasting Erections in Males Taking Methylphenidate ADHD Medications and Has Approved Label Changes. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-rare-risk-long-lasting-erections-males-taking. Last accessed March 30, 2023.

111. Rounsaville BJ. Treatment of cocaine dependence and depression. Biol Psychiatry. 2004;56(10):803-809.

112. Torrens M, Fonseca F, Mateu G, Farre M. Efficacy of antidepressants in substance use disorders with and without comorbid depression: a systematic review and meta-analysis. Drug Alcohol Dependence. 2005;78(1):1-22.

113. Gates S, Smith LA, Foxcroft DR. Auricular acupuncture for cocaine dependence. Cochrane Database Syst Rev. 2006;1:CD005192.

114. Cocaine Anonymous. About CA. Available at https://ca.org/about-ca/. Last accessed March 30, 2023.

115. Narcotics Anonymous. 2015 Membership Survey. Available at https://www.na.org/admin/include/spaw2/uploads/pdf/pr/MembershipSurvey_2016.pdf. Last accessed March 30, 2023.

116. Humphreys K, Wing S, McCarty D, et al. Self-help organizations for alcohol and drug problems: toward evidence-based practice and policy. J Subst Abuse Treat. 2004;26(3):151-158.

117. Kelly JF, Stout RL, Magill M, Tonigan JS, Pagano ME. Spirituality in recovery: a lagged meditational analysis of Alcoholics Anonymous' principal theoretical mechanism of behavior change. Alcohol Clin Exp Res. 2011;35(3):454-463.

118. Chappel JN, DuPont RL. Twelve-step and mutual-help programs for addictive disorders. Psychiatr Clin North Am. 1999;22(2):425-446.

119. Weiss RD, Griffin ML, Gallop R, et al. Self-help group attendance and participation among cocaine dependent patients. Drug Alcohol Dependence. 2000;60(2):169-177.

120. Ahmadi J, Kampman K, Dackis C. Outcome predictors in cocaine dependence treatment trials. Am J Addict. 2006;15(6):434-439.

121. Girardeau P, Navailles S, Durand A, Vouillac-Mendoza C, Guillem K, Ahmed SH. Relapse to cocaine use persists following extinction of drug-primed craving. Neuropharmacology. 2019;155:185-193.

122. Dackis CA, O'Brien CP. Cocaine dependence: a disease of the brain's reward centers. J Subst Abuse Treat. 2001;21(3):111-117.

123. Davis L, Uezato A, Newell JM, Frazier E. Major depression and comorbid substance use disorders. Curr Opin Psychiatry. 2008;21(1): 14-18.

124. Ahmadi J, Kampman KM, Oslin DM, Pettinati HM, Dackis C, Sparkman T. Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment. Am J Addict. 2009;18(1):81-86.

125. McKay JR, Lynch KG, Shepard DS, Pettinati HM. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes. Arch Gen Psychiatry. 2005;62(2):199-207.

126. Lookatch SJ, Wimberly AS, McKay JR. Effects of social support and 12-step involvement on recovery among people in continuing care for cocaine dependence. Subst Use Misuse. 2019;54(13):2144-2155.

127. Gossop M, Stewart D, Marsden J. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study. Addiction. 2008;103(1):119-125.


Copyright © 2023 NetCE, PO Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.